| Biological Information | |
|---|---|
| Background Information: | CCL2 is a protein involved in chemoattraction which attracts monocytes, activated T cells, basophils, NK cells, and immature dendritic cells to the site of inflammation. CCL2 acts as an agonist on CCR receptors including CCR2, CCR3, and CCR5. Additionally, it is believed to reduce IL-12 production by dendritic cells and promote a Th2 phenotype in CD4+ T cells. Implicated in the pathology of multiple sclerosis, atherosclerosis, and allergic asthma. Provided as 5 μg of dry powder alongside reconstitution buffer. |
| Target Class: | Cytokine |
| Family: | Chemokine |
| Target Name: | CCL2 |
| Usage | |
| Product Type: | Recombinant Proteins |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Recombinant Human CCL2
Recombinant Human CCL2 is an agonist for CCR2, CCR3, CCR5. This product is provided as 5μg of dry powder alongside reconstitution buffer.
Datasheets
92-1001 Datasheet
View Document